# A Pilot Study of Sildenafil in COVID-19

> **NCT04304313** · PHASE3 · UNKNOWN · sponsor: **Tongji Hospital** · enrollment: 10 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Sildenafil citrate tablets

## Key facts

- **NCT ID:** NCT04304313
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-09
- **Primary completion:** 2020-03-01
- **Final completion:** 2020-11-09
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2020-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04304313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04304313, "A Pilot Study of Sildenafil in COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04304313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*